VERSANT VENTURE MANAGEMENT, LLC
Latest 13F filing data - Q4 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
 | GLUE | 4.38M | $68.72M |
 | LENZ | 2.66M | $42.51M |
 | SKYE | 2.01M | $1.51M |
 | JBIO | 1.53M | $23.54M |
 | CTNM | 543K | $6.20M |
 | TPST | 270K | $774.25K |
 | CRSP | 149K | $7.80M |
Monte Rosa Therapeutics, Inc.
GLUE
Shares Held
4.38M
Value
$68.72M
LENZ Therapeutics, Inc.
LENZ
Shares Held
2.66M
Value
$42.51M
Skye Bioscience, Inc.
SKYE
Shares Held
2.01M
Value
$1.51M
Jade Biosciences, Inc.
JBIO
Shares Held
1.53M
Value
$23.54M
Contineum Therapeutics, Inc. Class A Common Stock
CTNM
Shares Held
543K
Value
$6.20M
Tempest Therapeutics, Inc.
TPST
Shares Held
270K
Value
$774.25K
CRISPR Therapeutics AG
CRSP
Shares Held
149K
Value
$7.80M